MRK
Merck & Company Inc
147.20$
+1.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.6% | 31.4% | 26.1% | 16.1% | 25.8% | 34.4% | 24.7% | 29.0% | 32.2% | 21.6% | 33.5% | 25.4% | |
| 15.8% | 16.1% | 13.7% | 11.6% | 10.7% | 9.3% | 8.7% | 6.6% | 6.6% | 6.4% | 7.0% | 9.0% | |
| 0.7% | 0.8% | 0.8% | 0.8% | 0.8% | 1.1% | 1.1% | 1.0% | 0.9% | 1.1% | 1.2% | 1.3% | |
| -29.8% | 4.7% | 9.0% | -3.6% | 2.6% | 5.3% | 3.6% | 5.7% | 3.4% | – | – | – | |
| 4.3% | -0.7% | -6.5% | -12.5% | -3.7% | -5.3% | -11.1% | -7.9% | -4.7% | -3.7% | -5.7% | -10.7% | |
| 5.5% | 3.2% | 4.1% | 4.7% | 6.2% | 8.9% | 11.3% | 9.1% | 7.4% | 6.4% | 5.3% | 6.3% | |
| -0.9% | -12.0% | -8.1% | 6.7% | 10.2% | -6.7% | -22.7% | -34.0% | -8.4% | -23.4% | -12.1% | -21.2% | |
| 12.4% | 13.0% | 12.9% | 12.9% | 12.2% | 14.6% | 15.0% | 13.6% | 11.8% | 12.4% | 12.2% | 12.6% | |
| -18.2% | -10.6% | -8.6% | -10.0% | -21.5% | -12.2% | -3.1% | -1.7% | 0.6% | -2.2% | -2.0% | -7.8% | |
| -9.3% | 8.8% | -3.3% | -2.8% | 2.0% | 3.2% | 12.1% | 3.3% | -3.8% | 7.0% | 3.6% | 17.5% | |
| -35.8% | -13.6% | -22.7% | -24.9% | -31.1% | -22.7% | -6.8% | 5.3% | -15.4% | -8.0% | -11.0% | -3.0% | |
| -19.4% | 2.7% | -5.0% | -1.1% | 4.4% | 5.0% | -4.3% | 0.0% | 7.8% | -9.8% | 10.0% | 2.1% | |
| 15.5% | 28.5% | 22.0% | 11.4% | 19.6% | 25.5% | 13.4% | 19.8% | 24.8% | 15.2% | 28.2% | 19.0% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.